
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current YMAB market cap is 202.35M. The company's latest EPS is USD -0.6561 and P/E is -6.83.
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 23.36M | 19.93M | 22.8M | 18.46M | 26.5M |
Operating Income | -7.68M | -6.91M | -9.79M | -8.57M | -5.94M |
Net Income | -988k | -6.63M | -9.25M | -7M | -6.79M |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 20.75M | 34.9M | 65.27M | 84.82M | 87.69M |
Operating Income | -119.94M | -115.43M | -94.85M | -25.67M | -31.2M |
Net Income | -119.34M | -55.28M | -95.61M | -21.43M | -29.67M |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 127.87M | 123.32M | 144.04M | 120.92M | 119.9M |
Total Liabilities | 26.88M | 24.13M | 48.7M | 28.49M | 27.9M |
Total Equity | 100.99M | 99.19M | 95.34M | 92.43M | 92M |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 132.05M | 212.78M | 141.46M | 127.87M | 119.9M |
Total Liabilities | 26.21M | 32.68M | 32.24M | 26.88M | 27.9M |
Total Equity | 105.84M | 180.11M | 109.22M | 100.99M | 92M |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -27.23M | -3.48M | -3.18M | -13.84M | -15.71M |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | 100k | 588k | 2.35M | 3.33M | 4.31M |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -91.23M | -102.56M | -75.92M | -27.23M | -15.71M |
Investing | -2.79M | 61.04M | N/A | N/A | N/A |
Financing | 2M | 108.31M | 84k | 100k | 4.31M |
Market Cap | 202.35M |
Price to Earnings Ratio | -6.83 |
Price to Sales Ratio | 2.31 |
Price to Cash Ratio | 3.01 |
Price to Book Ratio | 2.2 |
Dividend Yield | - |
Shares Outstanding | 45.22M |
Average Volume (1 week) | 236.84k |
Average Volume (1 Month) | 367.45k |
52 Week Change | -69.56% |
52 Week High | 17.7775 |
52 Week Low | 4.25 |
Spread (Intraday) | 0.01 (0.22%) |
Company Name | Y mAbs Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.ymabs.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions